Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew ...

Use “priming” to quiet self-critique and do meaningful work. Nil Demircubuk, author of the new Down to Earth, explains the ...

There will be no hope of restoring political support for pandemic preparedness research, nor public acceptance of it, if virologists seek to continue under a business-as-usual model. Public inclusion ...

Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on ...

Third quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $51.3 million -- -- December 20, ...